Edwards E H, Sprague E A, Schwartz C J
Department of Pathology, University of Texas Health Science Center, San Antonio 78284.
Exp Mol Pathol. 1988 Jun;48(3):353-72. doi: 10.1016/0014-4800(88)90071-8.
Based upon the observation that the multivalent ligand cationized ferritin (CF) alters the cell surface distribution of anionic domains and significantly enhances the adsorptive endocytosis of 125I-labeled human serum albumin, these studies were undertaken to probe the influence of CF on receptor-mediated low-density lipoprotein (LDL) endocytosis and the nature of the mechanisms involved. A brief 1-min exposure of normal receptor upregulated fibroblasts to CF (0.2 mg/ml) resulted in a significant decrease (P less than 0.001) in the subsequent internalization and degradation of 125I-LDL. Studies with receptor downregulated normal fibroblasts indicated that CF pretreatment did not measurably influence 125I-LDL internalization and only slightly inhibited its degradation (P less than 0.05). In contrast, CF pretreatment of FH receptor-negative mutant skin fibroblasts resulted in a modest but significant increase in both 125I-LDL internalization and degradation (P less than 0.05). Scatchard analyses of binding data indicated that CF-pretreated upregulated normal fibroblasts exhibit a single class of LDL binding sites with an affinity, Kd = 24.7 +/- 4.1 nM, almost 10-fold lower than the affinity of binding sites in untreated controls, Kd = 3.2 +/- 0.06 nM. Increasing either the concentration or the duration of CF exposure resulted in additional inhibition of LDL internalization and degradation associated primarily with a decrease in the number of LDL binding sites without any further change in binding affinity. Total cellular LDL receptor-mediated binding, measured using an octylglucoside solubilization-filtration assay, confirmed the CF-induced decrease in high-affinity LDL binding. Pulse-chase experiments showed that CF had no direct influence on LDL degradation, nor did it influence targeting of the LDL-containing endosome toward exocytosis. Further, restoration of LDL receptor function to control values after CF pretreatment required de novo protein synthesis. The normal feedback inhibition of HMG-CoA reductase activity was nearly abolished by CF pretreatment. Additionally, CF pretreatment was found to induce not only a redistribution of surface anionic sites, but also a very rapid internalization of surface components labeled with 4,4'-[3H]diisothiocyano-1,2..diphenylethane-2,2'-disulfonic acid. It is concluded that the inhibitory influence of CF on LDL endocytosis is mediated via a decrease in the affinity and in the number of functional LDL receptors.
基于多价配体阳离子化铁蛋白(CF)可改变阴离子结构域的细胞表面分布并显著增强125I标记的人血清白蛋白的吸附性胞吞作用这一观察结果,进行了这些研究以探究CF对受体介导的低密度脂蛋白(LDL)胞吞作用的影响以及所涉及机制的性质。将正常受体上调的成纤维细胞短暂暴露于CF(0.2 mg/ml)1分钟,导致随后125I-LDL的内化和降解显著减少(P<0.001)。对受体下调的正常成纤维细胞的研究表明,CF预处理对125I-LDL的内化没有可测量的影响,仅轻微抑制其降解(P<0.05)。相比之下,对FH受体阴性突变皮肤成纤维细胞进行CF预处理导致125I-LDL的内化和降解适度但显著增加(P<0.05)。对结合数据的Scatchard分析表明,经CF预处理的上调正常成纤维细胞表现出一类LDL结合位点,其亲和力Kd = 24.7±4.1 nM,几乎比未处理对照中结合位点的亲和力Kd = 3.2±0.06 nM低10倍。增加CF暴露的浓度或持续时间会导致LDL内化和降解的进一步抑制,这主要与LDL结合位点数量的减少有关,而结合亲和力没有任何进一步变化。使用辛基葡糖苷增溶-过滤测定法测量的总细胞LDL受体介导的结合证实了CF诱导的高亲和力LDL结合的减少。脉冲追踪实验表明,CF对LDL降解没有直接影响,也不影响含LDL的内体向胞吐作用的靶向。此外,CF预处理后将LDL受体功能恢复到对照值需要重新合成蛋白质。CF预处理几乎消除了HMG-CoA还原酶活性的正常反馈抑制。此外,发现CF预处理不仅会诱导表面阴离子位点的重新分布,还会导致用4,4'-[3H]二异硫氰酸-1,2..二苯乙烷-2,2'-二磺酸标记的表面成分非常快速的内化。得出的结论是,CF对LDL胞吞作用的抑制作用是通过功能性LDL受体的亲和力和数量的降低介导的。